GlassScriptPhysician profile
Adam Khalil
NPI 1225448616
$3,388.07
in general payments reported to CMS, 2019-2025
10 companies · $256 in 2025
The $256 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $176 · 2021: $174 · 2022: $1,071 · 2023: $24.78 · 2024: $1,687 · 2025: $256.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,304 · Food and Beverage: $663.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,303.75 |
| Food and Beverage | $663.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $1,596.60 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Medtronic, INC. | $1,224.68 | 2021-2022 | |
| Penumbra, INC. | $217.45 | 2024-2025 | Indigo System, Penumbra System |
| Medtronic USA, INC. | $176.43 | 2020 | |
| Stryker Corporation | $43.03 | 2025 | Inthrill Thrombectomy Catheter, Artix Mt |
| Becton, Dickinson and Company | $30.17 | 2025 | Rotarexs 6 F X 135 Cm |
| Bard Peripheral Vascular, INC. | $28.40 | 2025 | Lifestream |
| Curonix LLC | $26.57 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Janssen Pharmaceuticals, INC | $24.78 | 2023 | Xarelto |
| Aveo Pharmaceuticals, INC. | $19.96 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Khalil listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.